| Literature DB >> 24376594 |
Haibo Dong1, Shaoqing Wang1, Yuanyuan Jia1, Yingdong Ni1, Yuanshu Zhang1, Su Zhuang2, Xiangzhen Shen3, Ruqian Zhao1.
Abstract
PURPOSE: The mechanism underlying the decline in milk quality during periods of feeding high-concentrate diets to dairy ruminants is not well documented. The aim of this study was to investigate the metabolic changes in the liver that contribute to the input of substrate precursors to the mammary gland after feeding a high-concentrate diet to lactating goats for a long period. EXPERIMENTALEntities:
Mesh:
Substances:
Year: 2013 PMID: 24376594 PMCID: PMC3871605 DOI: 10.1371/journal.pone.0082850
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Rumen fluid pH values.
Data were analyzed for differences due to diet, time, and their interactions by Univariate using the General Linear Models of SPSS 11.0 for Windows (StatSoft Inc, Tulsa, OK, USA). Values are mean ± standard error of the mean (SEM).
Comparison of plasma concentrations of glucose, non-esterified fatty acids (NEFA), triglyceride (TG) and leptin.
| Diet | |||
| Parameters | LC | HC |
|
| Glucose | 3.00±0.06 | 3.3±0.05 | 0.014 |
| NEFA (μmol/L) | 175.87±55.12 | 969.52±293.20 | 0.071 |
| TG (mmol/L) | 0.19±0.06 | 0.18±0.03 | 0.659 |
| Leptin (ng/mL) | 1.75±0.57 | 2.01±0.78 | 0.058 |
LC, low concentrate; HC, high concentrate; NEFA, non-esterified fatty acid. TG, triglyceride. Values are mean ± standard error of the mean (SEM), n = 4/group.
The percentage of fat, protein, and lactose in milk from control and treatment group goats.
| Item | Diet | Time | Effect, | |||||
| 0–2 W | 3–4 W | 5–6 W | 7–9 W | Diet | Time | Diet × Time | ||
| Fat | LC | 4.15±0.43 | 4.01±0.38 | 3.76±0.88 | 3.90±0.53 | |||
| HC | 3.09±0.63* | 3.34±1.15 | 3.20±1.22* | 3.04±0.89** | 0.931 | 0.021 | 0.935 | |
| Protein | LC | 2.90±0.35 | 3.26±0.16 | 3.10±0.67 | 3.18±0.10 | |||
| HC | 2.88±0.28 | 2.92±0.40 | 2.62±0.41* | 2.68±0.22** | 0.516 | 0.007 | 0.372 | |
| Lactose | LC | 4.82±0.23 | 4.59±0.33 | 4.72±0.28 | 4.78±0.29 | |||
| HC | 4.90±0.28 | 4.96±0.09* | 5.00±0.10 | 4.95±0.13* | 0.845 | 0.017 | 0.646 | |
LC, low concentrate; HC, high concentrate; Values are mean ± standard error of the mean (SEM), n = 4/group. * p<0.05, ** P<0.01 vs. LC.
Lipopolysaccharide (LPS) levels in plasma and in rumen fluid of control and treatment group goats.
| Items | Diet | SEM | Effect, | |||
| LC | HC | Diet | Time | Diet × Time | ||
| Plasma LPS, EU/mL | ||||||
| 0h | 0.24 | 0.32 | 0.05 | 0.249 | 0.002 | 0.716 |
| 4h | 0.09 | 0.14 | ||||
| 8h | 0.07 | 0.06 | ||||
| Rumen LPS | ||||||
| 0h | 38,854 | 48,064 | 20,383 | 0.717 | 0.084 | 0.98 |
| 4h | 14,466 | 16,058 | ||||
| 8h | 63,359 | 70,418 | ||||
LC, low concentrate; HC, high concentrate; LPS, lipopolysaccharide; Values are mean ± standard error of the mean between two groups (SEM), n = 4/group.
1 Statistical analysis conducted on log10−transformd date.
Plasma cytokines and acute phase protein levels in control and treatment group goats.
| Diet | |||
| Parameters | LC | HC |
|
| IL-6(μg/mL) | 221.32±42.63 | 345.45±56.33 | 0.163 |
| TNF-α(ng/mL) | 715.42±49.67 | 984.36±130.46 | 0.126 |
| SAA(μg/mL) | 90.62±15.67 | 246.04±37.37 | 0.020 |
| HP(μg/mL) | 209.50±21.99 | 307.54±35.77 | 0.087 |
| LBP(ng/mL) | 23.32±6.10 | 34.48±5.74 | 0.163 |
LC, low concentrate; HC, high concentrate; HP, haptoglobin; IL-6, interleukin-6; LBP, lipopolysaccharide binding protein; SAA, serum amyloid A protein; TNF-α, tumour necrosises factor α. Values are mean ± standard error of the mean (SEM), n = 4/group.
Figure 2Plasma cortisol concentration (A) and hepatic glucocorticoid receptor (GR) protein expression (B).
The concentrations of cortisol were significantly up-regulation and the GR protein expression was significantly down-regulation. Values are mean ± standard error of the mean (SEM); *p<0.05 vs. LC.
Figure 3Hierarchical cluster analysis of the differentially expressed transcripts (n = 155).
155 transcripts were differentially expressed (adjusted p<0.01). Red and green colors reflect the high and low intensities, respectively.
Figure 4Co-expression network for k-core genes in liver of HC goats.
Co-expression networks were for immune and inflammatory responses (A), lipid metabolism (B), protein (or amino acid) metabolism (C), and carbohydrate metabolism (D) in the liver of HC goats. Circles in the figure represent genes (red circle means up–regulation; blue circle means down-regulation), lines represent regulation relationships between genes (solid lines mean a positive correlation of the expression between genes; dotted lines mean a negative correlation), rectangles represent genes for immunity and stress, triangles represent carbohydrate metabolism, hexagons represent lipid metabolism, and diamonds represent protein metabolism.
Figure 5Hepatic gene expression profile detected by real-time PCR.
(A) mRNA expression of the key genes for inflammatory response and acute phase responses. (B) mRNA expression of the key genes for glucometabolism. (C) mRNA expression of the key genes for lipid metabolism. Beta-actin was used as the reference gene for gene expression. Values are mean ± SEM. , *p<0.05 vs. LC.
Nutrient composition and forge to concentrate ratio (F:C) of the TMR.
| Diet | ||
| Items | LC | HC |
| Leymus chinensis | 40 | 26.7 |
| Alfalfa silage | 20 | 13.3 |
| Corn | 22.99 | 23.24 |
| Bran | 0 | 20.77 |
| Soybean meal | 15 | 13.66 |
| Limestone | 0.65 | 1.43 |
| CaHPO4 | 0.46 | 0 |
| Premix | 0.5 | 0.5 |
| NaCl | 0.4 | 0.4 |
| Total | 100 | 100 |
| Nutrient levels | ||
| ME (MJ/kg) | 5.63 | 5.83 |
| DCP % | 9.9 | 10 |
| NDF % | 36.64 | 34.55 |
| ADF % | 24.74 | 20.35 |
| EE % | 2.87 | 3.21 |
| NFC % | 31.76 | 35 |
| Ca % | 0.8 | 0.9 |
| P % | 0.33 | 0.38 |
| H20% | 88.4 | 88.1 |
a Amount of premix added, VA: 6000 IU/kg, VD: 2500 IU/kg, VE: 80 mg/kg, Cu: 6.25 mg/kg, Fe: 62.5 mg/kg, Zn: 62.5 mg/kg, Mn: 50 mg/kg, I: 0.25 mg/kg, Se: 0.125 mg/kg, Co: 0.125 mg/kg, Mo: 0.125 mg/kg.
b Nutrient levels were calculated values.
LC, low concentrate; HC, high concentrate.
PCR primers for immunity and stress, lipid metabolism and carbohydrate metabolism.
| Target genes | Genbank accession | PCR products (bp) | Primer sequences |
| β-actin | AF_481159 | 260 | F:5′-CGGGATCCATCCTGCGTCTGGACCTG-3′ |
| R:5′-GGAATTCGGAAGGAAGGCTGGAAGAG-3′ | |||
| ACAA2 | XM_004020663.1 | 165 | F:5′-TGTCTGCTGGCAAAGTCTCACC-3′ |
| R:5′-AACCAGAGCCACAGAGCCTGTT-3′ | |||
| HADH | XM_004009637.1 | 197 | F:5′-GAGTTTGTGGCGAAGACCCTGA-3′ |
| R:5′-GGCTTGTGATCTGCAAAGAGGAAG-3′ | |||
| CPT1 | Y18830.1 | 158 | F:5′-GCTTTGATCGACACTTGTTTGCTC-3′ |
| R:5′-GCAAAGCAGCCGATGTTCACT-3′ | |||
| CPT2 | BC105423.1 | 157 | F:5′-GCTTTGATCGACACTTGTTTGCTC-3′ |
| R:5′-GCAAAGCAGCCGATGTTCACT-3′ | |||
| ACSL1 | NM_001076085.1 | 191 | F:5′-GCAACCCCAAAGGAGCAATG-3′ |
| R:5′-AGCAGCCTGATATCTCCTTGG-3′ | |||
| PPARα | HM600810.1 | 243 | F:5′-TAAAGCCAACCAAGATAACCC-3′ |
| R:5′-TCACCAAACAGCCGAAGA-3′ | |||
| ATGL | GQ918145.1 | 180 | F:5′-GGAGCTTATCCAGGCCAAT-3′ |
| R:5′-TGCGGGCAGATGTCACTC-3′ | |||
| ACSS1 | BC055008.1 | 242 | F:5′-TCCTTGGCTGGGAGGATCAA-3′ |
| R:5′-TGTTGTCTGTCCTGTGAGCCA-3′ | |||
| LPL | JQ670882.1 | 235 | F:5′-TTCAGAGGCTATTACTGGAAATCC-3′ |
| R:5′-ATGTCAATCACAGCATTCATTCTACT-3′ | |||
| SCD | AF325499.1 | 178 | F:5′-TGCTGACAACTTATCTGGATGC-3′ |
| R:5′-AAGGAATCCTGCAAACAGCTA-3′ | |||
| DGAT1 | DQ380249.1 | 240 | F:5′-TGCCTCAGACACTTCTACAAGCC-3′ |
| R:5′-GCCCGATGATGAGTGACAGC-3′ | |||
| DGAT2 | AJ519787.1 | 234 | F:5′-CACTGGCTCCAGCATCCTCTC-3′ |
| R:5′-TTCTTGGGTGTGTTCCAGTCA-3′ | |||
| FADS1 | XM_004019593.1 | 187 | F:5′-CCTTGCTGCCTCTATACTTCCA-3′ |
| R:5′-ACAAACCAGTTGCTTTCCAGGA-3′ | |||
| FADS2 | AY.850395.1 | 257 | F:5′-AGAGCATCGCCTGGTTCACTA-3′ |
| R:5′-CCTTGTGGAAGACATTGGGTTT-3′ | |||
| ACACA | NM_001009256 | 230 | F:5′-CATGGAAATGTACGCGGACC-3′ |
| R:5′-GGTGGTAGATGGGAAGGAGGA-3′ | |||
| FAS | XM_004013447.1 | 112 | F:5′-TGCTCATTCACTCGGGTTCT-3′ |
| R:5′-AGGTATGCCCGCTTTTCG-3′ | |||
| PPARγ | JN854246.1 | 238 | F:5′-CATTTCTGCTCCGCACTAC-3′ |
| R:5′-TGGAACCCTGACGCTTT-3′ | |||
| PC | NM_177946 | 187 | F:5′-TCGCACCATGTATGTCATCCC-3′ |
| R:5′-AGGCTTTTTTAAAGGCAGAGGG-3′ | |||
| FBP1 | NM_001034447 | 106 | F:5′-GCGGTCAAAGCCATCTCCAC-3′ |
| R:5′-CATCCAGCTTCTTCACTTGATCTCC-3′ | |||
| G6Pase | EF062861 | 158 | F:5′-AATGTCATGTTGTGGTTGGGATTCT-3′ |
| R:5′-GCATTGTAGATGCTCTGGATGTGG-3′ | |||
| HK1 | AM492192 | 139 | F:5′-GCGGCTCTCTGATAAAACTCTGTTA-3′ |
| R:5′-TGAGCCATCGGGAATAGACCTTAC-3′ | |||
| PYGL | AY827551 | 150 | F:5′-GCCTTCCCAGATCAGGTTGC-3′ |
| R:5′-GTGGTTGGTGTAGGCGAAGGTC-3′ | |||
| LEPR | NM_001009763 | 110 | F:5′-GGAAGGAGTAGGGAAACCGAAGA-3′ |
| R:5′-TTGAGGAGGAGATTATTATTGGCAC-3′ | |||
| GYS2 | NM_001192905 | 131 | F:5′-TTGGGCGGTATCTTTGTG-3′ |
| R:5′-AGCACAATGGACGGAAGC-3′ | |||
| GSK3α | NM_001102192.1 | 250 | F:5′-TGGCTTACACAGACATCAAA-3′ |
| R:5′-TCGGGCACATATTCCAGCAC-3′ | |||
| GSK3β | NM_001101310.1 | 249 | F:5′-AGACAAAGATGGCAGCAAGGTGAC-3′ |
| R:5′-ACGCAATCGGACTATGTTAC-3′ | |||
| GLUT2 | NM_001103222.1 | 268 | F:5′-CATCCATCTTCCTCTTTGTCTG-3′ |
| F:5′-GATTTTCCTTTGGTTTCTGG-3′ | |||
| IR | XM_590552.4 | 275 | F:5′-GACGCAGGCCGGAGATGACCA-3′ |
| R:5′-GCTCCTGCCCGAAGACCGACTC-3′ | |||
| SAA | AF540564.1 | 121 | F:5′-CATCCTGCGTCTGGACCTGG-3′ |
| R:5′-TTCCTTGATGTCACGGACGATTT-3′ | |||
| TLR4 | JQ342090.1 | 195 | F: |
| R: | |||
| MyD88 | JQ308783.1 | 98 | F:5′-ACAAGCCAATGAAGAAAGAG-3′ |
| R:5′-GAGGCGAGTCCAGAACC-3′ | |||
| CD14 | NM_001077209.1 | 239 | F:5′-CCGTTCAGTGTATGGTTGCC-3′ |
| R:5′-TGCTTCGGGTCGGTGTT-3′ | |||
| HP | XM_004015111.1 | 162 | F:5′-TAATGCCCATCTGCCTAC-3′ |
| R:5′-CGCCCTCATAGTGTTTCA-3′ | |||
| IL-1β | D63351.1 | 172 | F: |
| R: | |||
| TNF-α | AF276985.1 | 173 | F: |
| R:5′-CCTGAAGAGGACCTGCGAGTAG-3′ | |||
| LBP | XM_004014566.1 | 138 | F: |
| F: | |||
| CRP | NM_001144097.1 | 134 | F: |
| F: |
ACAA2, acetyl-coenzyme A acyltransferase 2; ACACA, acetyl-coenzyme A carboxylase alpha; ATGL, adipose triglyceride lipase; ACSL1, acyl-CoA synthetase long-chain family member 1; ACSS1, acyl-CoA synthetase short-chain family member 1; CD14, CD14 molecule; CPT1, carnitine palmityl transferase1; CPT2, carnitine palmityl transferase 2; CRP, C-reactive protein; DGAT1, diacylglycerol acyltransferase 1; DGAT2, diacylglycerol acyltransferase 2; FADS1, fatty acid desaturase 1; FADS2, fatty acid desaturase 2; FBP1, fructose-1,6-bisphosphatase 1; PPARα, peroxisome proliferator-activated receptor α; FAS, fatty acid synthase; G6Pase, glucose-6-phosphatase; GLUT2, solute carrier family 2 (facilitated glucose transporter), member 2; GYS2, glycogen synthase 2; GYSK3α, glycogen synthase kinase 3 alpha; GYSK3β, glycogen synthase kinase 3 beta; HADH, 3-hydroxyacyl-CoA dehydrogenases; HK1, hexokinase 1; HP, haptoglobin; IL1β; interleukin-1beta; IR, insulin receptor; LBP, lipopolysaccharide binding protein; LEPR, leptin receptor; LPL, lipoprotein lipase; MyD88, myd88; PC, pyruvate carboxylase; PPARγ, peroxisome proliferators-activated receptor γ; PYGL, liver glycogen phosphorylase; SAA, serum amyloid A protein; SCD, stearoyl-CoA desaturase; TLR4, toll-like receptor 4; TNFα, tumor necrosis factor alpha.